In Zheng et al.,¹ there was an error in Figure 2C,D on page 1903. Following the publication, author discovered that the incorrect version of scratch and transwell assays were used for Figure 2C,D. They reperformed the analysis and the correct Figure 2 is shown below.

On page 1899, in Section 2.4, the following sentence “Tmod3 targeted siRNA (sh Tmod3) (F:5′ GCCATTCCGTAAGGACTTAGA 3′; R;5′ GCCATTCCGTAAGGACTTAGA 3′) and their corresponding controls were synthesized by Gene Pharma Co (Shanghai, China)” should be corrected to “Tmod3 targeted short hairpin RNA (shRNA) (sh Tmod3) (F:5′ GCCATTCCGTAAGGACTTAGA 3′;) and their corresponding controls were synthesized by Gene Pharma Co.”

Additionally, in Table S2, TMOD3 primer sequences were written erroneously. The corrected Table S2 is included in the supporting information.

The authors confirm that the results and conclusion of the article remain unchanged.

The authors apologize for these errors.

在 Zheng 等人中，¹第 1903 页的图 2C、D 中有一个错误。出版后，作者发现图 2C、D 使用了错误版本的划痕和 transwell 检测。他们重新进行了分析，正确的图 2 如下所示。

在第 1899 页，第 2.4 节中，以下句子“Tmod3 靶向 siRNA (sh Tmod3) (F:5' GCCATTCCGTAAGGACTTAGA 3'; R;5' GCCATTCCGTAAGGACTTAGA 3') 及其相应的对照由 Gene Pharma Co (Shanghai, China )”应更正为“Tmod3 靶向短发夹 RNA (shRNA) (sh Tmod3) (F:5' GCCATTCCGTAAGGACTTAGA 3';) 及其相应的对照由 Gene Pharma Co. 合成。”

此外，在表 S2 中，错误地写入了 TMOD3 引物序列。更正后的表 S2 包含在支持信息中。

作者确认文章的结果和结论保持不变。

作者为这些错误道歉。